» Articles » PMID: 15609785

The Importance of Engaging Policy-makers at the Outset to Guide Research on and Introduction of Vaccines: the Use of Policy-maker Surveys

Overview
Publisher Biomed Central
Date 2004 Dec 22
PMID 15609785
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Face-to-face surveys of policy-makers and other influential leaders are a useful tool to identify, at an early stage, (a) major issues regarding the introduction of a new vaccine, (b) persons and groups in a country who play a major decision-making or influential role in the introduction of vaccines, (c) potential obstacles to the introduction of vaccines, and (d) data-needs of policy-makers to overcome these obstacles. By surveying the opinions and beliefs of those who will make or influence decisions on whether to introduce a new vaccine, these studies can help ensure that research activities respond to the needs of policy-makers in countries endemic for the target diseases. These surveys can also inform vaccine-introduction strategies by identifying financially and politically feasible means of distributing, targeting, and financing the vaccines. This paper describes the methodology used in conducting such surveys and discusses methodological issues. It also presents lessons learnt from two policy-maker surveys carried out in several Asian countries in regard to new-generation vaccines against cholera, typhoid fever, and shigellosis; and future vaccines against dengue fever/dengue haemorrhagic fever.

Citing Articles

Stakeholder Priorities for ART Initiation and Early Retention Interventions in Malawi: A Qualitative Study Comparing International and National Perspectives.

Hariprasad S, Phiri K, Thorp M, Holland K, Nyirenda R, Gupta S Res Sq. 2024; .

PMID: 38196656 PMC: 10775367. DOI: 10.21203/rs.3.rs-3725505/v1.


An Assessment of National Maternal and Child Health Policy-Makers' Knowledge and Capacity for Evidence- Informed Policy-Making in Nigeria.

Uneke C, Sombie I, Keita N, Lokossou V, Johnson E, Ongolo-Zogo P Int J Health Policy Manag. 2017; 6(6):309-316.

PMID: 28812823 PMC: 5458792. DOI: 10.15171/ijhpm.2016.132.


Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania.

Romore I, Njau R, Semali I, Mwisongo A, Ba Nguz A, Mshinda H Malar J. 2016; 15:143.

PMID: 26956944 PMC: 4782348. DOI: 10.1186/s12936-016-1197-6.


Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar.

Schaetti C, Ali S, Chaignat C, Khatib A, Hutubessy R, Weiss M PLoS One. 2012; 7(7):e41527.

PMID: 22844489 PMC: 3402403. DOI: 10.1371/journal.pone.0041527.


Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions.

Brooks A, Ba-Nguz A Health Policy Plan. 2012; 27 Suppl 2:ii50-61.

PMID: 22513733 PMC: 3328760. DOI: 10.1093/heapol/czs039.